Araceli Biosciences delivers high-performance scientific tools for tissue and cell-based biomarker discovery, drug discovery and drug development. Visit our website to learn more about Araceli Biosciences.
Total raised: $11.2M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.04.2025 | Seed | $11.2M | - |
Mentions in press and media 2
| Date | Title | Description |
| 24.04.2025 | Araceli Biosciences Closes $11.2M Seed Financing | Araceli Biosciences, a Portland, OR-based biotechnology company for high-content imaging and AI-powered analysis, raised $11.2M in Seed funding. Bill Cortelyou, Board Chairman, was the lead investor. The company intends to use the funds to:... |
| - | Araceli Biosciences | “Araceli Biosciences delivers high-performance scientific tools for tissue and cell-based biomarker discovery, drug discovery and drug development. Visit our website to learn more about Araceli Biosciences.” |